Research database
SVF Research Library
Search 52,792 real PubMed studies on SVF and adipose-derived stem cells — 650 matching records.
650 results — page 1 of 28
- Level DNarrative ReviewEurope PMC
Mesenchymal Stromal Cells: Bridging the Gaps in Hematologic Disease Therapy
Narrative Review on Immune Modulation, published in Stem Cell Rev Rep (2026) — summary generated from the PubMed abstract.
- 2026
Stem Cell Rev Rep2 citations - Level DAnimal StudyEurope PMC
Efficacy of mesenchymal stem cell therapy for treating deep corneal ulcers and corneal perforation in cats: a retrospective study
Animal Study, published in J Feline Med Surg (2026) — summary generated from the PubMed abstract.
- 2026
J Feline Med Surg - Level DNarrative ReviewPubMed
Mesenchymal stem cell therapy for premature ovarian insufficiency: progress and challenges.
Narrative Review, published in J Ovarian Res (2026) — summary generated from the PubMed abstract.
- 2026
J Ovarian Res1 citations - Level DAnimal StudyPubMed
Application of adipose-derived mesenchymal stem cell 3D structure, Microblock, as a skin regeneration therapy.
Animal Study on Chronic Wound, published in Eur J Pharmacol (2026) — summary generated from the PubMed abstract.
- 2026
Eur J Pharmacol - Level BRandomized Controlled TrialPubMed
Adipose tissue-derived mesenchymal stromal cell therapy in nonischemic heart failure with reduced ejection fraction - ARIISE study design.
Randomized Controlled Trial on Cardiovascular Disease, Stroke Research, Immune Modulation, published in Future Cardiol (2026) — summary generated from the PubMed abstract.
- 2026
Future Cardiol - Level DLaboratory StudyEurope PMC
Combined Therapy with Pirfenidone, Metformin, and Mesenchymal Stem Cells Attenuates Bleomycin-Induced Pulmonary Fibrosis in Rats
Laboratory Study on Scar, Chronic Inflammation, published in Biomedicines (2026) — summary generated from the PubMed abstract.
- 2026
Biomedicines - Level DAnimal StudyPubMed
Adipose mesenchymal stem cell-derived nanovesicles as a therapeutic strategy for oral mucosal regeneration after chemotherapy in a rat model.
Animal Study on Chronic Wound, published in J Tissue Eng (2026) — summary generated from the PubMed abstract.
- 2026
J Tissue Eng - Level CCase Report / SeriesEurope PMC
Complete Healing After Umbilical Mesenchymal Stem Cell-Derived Exosome Therapy For a Refractory Complex Anal Fistula
Case Report / Series on Autoimmune Research, published in Cureus (2026) — summary generated from the PubMed abstract.
- 2026
Cureus - Level DAnimal StudyPubMed
Brown adipose-derived mesenchymal stromal cells improve sepsis-induced multiorgan dysfunction more than white adipose cells in obese rats.
Animal Study on Chronic Inflammation, published in Cytotherapy (2026) — summary generated from the PubMed abstract.
- 2026
Cytotherapy - Level ASystematic ReviewEurope PMC
Safety and Efficacy of Mesenchymal Stem Cell Therapy in Multiple System Atrophy: Systematic Review
Systematic Review with a reported sample of 123 on Neuroinflammation, Chronic Inflammation, Immune Modulation, published in Biologics (2026) — summary generated from the PubMed abstract.
- 2026
- n = 123
Biologics - Level BRandomized Controlled TrialEurope PMC
Advancing mesenchymal stem cell therapy for kidney diseases in companion animals: from mechanisms to clinical application
Randomized Controlled Trial on Chronic Kidney Disease, Immune Modulation, published in Front Vet Sci (2026) — summary generated from the PubMed abstract.
- 2026
Front Vet Sci - Level DAnimal StudyPubMed
Mesenchymal stromal cell therapy is a long-term regenerative approach for chronic radiation cystitis, involving coordinated modulation of the urothelial, immune, vascular, and fibrotic pathways.
Animal Study on Face & Skin, Systemic / IV, published in Stem Cell Res Ther (2026) — summary generated from the PubMed abstract.
- 2026
Stem Cell Res Ther - Level BClinical TrialPubMed
Mesenchymal stem cells therapy for Ischaemic stroke: Mechanism and progress.
Clinical Trial on Stroke Research, published in Exp Neurol (2026) — summary generated from the PubMed abstract.
- 2026
Exp Neurol - Level DNarrative ReviewEurope PMC
Advanced regenerative solutions in diabetic foot ulcer therapy: delivery of mesenchymal stem cells in injectable hydrogels
Narrative Review on Diabetic Foot, Chronic Wound, Chronic Inflammation, Immune Modulation, published in Stem Cell Res Ther (2026) — summary generated from the PubMed abstract.
- 2026
Stem Cell Res Ther1 citations - Level DNarrative ReviewPubMed
Mesenchymal stromal cells therapy for remodeling the joint microenvironment: mechanisms, nanotechnology-enhanced strategies, and translation prospects.
Narrative Review on Osteoarthritis, Cartilage Damage, published in Stem Cell Res Ther (2026) — summary generated from the PubMed abstract.
- 2026
Stem Cell Res Ther - Level DNarrative ReviewEurope PMC
Placental Mesenchymal Stem Cell-Derived Extracellular Vesicles (PMSC-EVs) as an Innovative Therapy for Diabetic Wound Healing
Narrative Review on Diabetic Foot, Chronic Wound, Scar, Immune Modulation, published in Int J Mol Sci (2026) — summary generated from the PubMed abstract.
- 2026
Int J Mol Sci - Level DLaboratory StudyPubMed
Mesenchymal Stem Cell-Derived Exosomes: A Novel Frontier in Regenerative Medicine and Immunotherapy.
Laboratory Study on Immune Modulation, published in Curr Stem Cell Res Ther (2026) — summary generated from the PubMed abstract.
- 2026
Curr Stem Cell Res Ther - Level CProspective StudyPubMed
Type 2 Diabetes-Induced Molecular and Functional Impairment of Adipose Tissue-Derived Mesenchymal Stromal Cells (ASCs) and Interferon Gamma Priming for Enhanced Diabetic ASC-Based Therapy.
Prospective Study on Type 2 Diabetes, Chronic Inflammation, Immune Modulation, published in Stem Cell Rev Rep (2026) — summary generated from the PubMed abstract.
- 2026
Stem Cell Rev Rep - Level DNarrative ReviewEurope PMC
Current trends in electrospun nanofibers combined with mesenchymal stem cells for diabetic foot ulcer repair and regenerative therapy
Narrative Review on Diabetic Foot, Chronic Wound, Chronic Inflammation, Immune Modulation, published in iScience (2026) — summary generated from the PubMed abstract.
- 2026
iScience - Level ASystematic ReviewPubMed
Total Knee Arthroplasty versus Mesenchymal Stem Cell Therapy for Moderate Knee Osteoarthritis: An Umbrella Analysis of Clinical Outcomes, Quality of Life, and Safety.
Systematic Review with a reported sample of 50 on Knee Osteoarthritis, Osteoarthritis, published in Ortop Traumatol Rehabil (2026) — summary generated from the PubMed abstract.
- 2026
- n = 50
Ortop Traumatol Rehabil - Level DNarrative ReviewPubMed
Exosomes From Adipose-Derived Mesenchymal Stem Cells: A New Prospective Therapy of Diabetic Foot Ulcer.
Narrative Review on Diabetic Foot, Chronic Wound, published in Biomed Res Int (2026) — summary generated from the PubMed abstract.
- 2026
Biomed Res Int - Level ASystematic ReviewEurope PMC
Optimizing dose and delivery route in mesenchymal stromal cells (MSCs)-based therapy: A systematic review of their implications for clinical efficacy
Systematic Review with a reported sample of 13 on Systemic / IV, published in Cell Transplant (2026) — summary generated from the PubMed abstract.
- 2026
- n = 13
Cell Transplant - Level DAnimal StudyPubMed
Mesenchymal stem cell-mediated delivery boosts the efficacy of suicide gene therapy based on retroviral replicating vectors in peritoneally disseminated cancer.
Animal Study on Face & Skin, published in Cancer Gene Ther (2026) — summary generated from the PubMed abstract.
- 2026
Cancer Gene Ther - Level DNarrative ReviewPubMed
The role of the mesenchymal stem cell therapy in bone regeneration of osteoporosis: clinical translation and limitations.
Narrative Review on Face & Skin, published in Int Immunopharmacol (2026) — summary generated from the PubMed abstract.
- 2026
Int Immunopharmacol
In-depth reviewed studies (full Thai translation)
Evidence system- Level ARandomized Controlled Trial
Cell-based versus corticosteroid injections for knee pain in osteoarthritis: a randomized phase 3 trial
A multicentre randomized trial in 480 knee osteoarthritis patients comparing SVF, BMAC and umbilical cord MSCs against corticosteroid injection. At 12 months no cell product outperformed the steroid control.
- 2023
- United States
- n = 480
- Level AMeta-analysis
Intra-articular Injection of Autologous Adipose-Derived Stem Cells or Stromal Vascular Fractions: Are They Effective for Patients With Knee Osteoarthritis? A Systematic Review With Meta-analysis of Randomized Controlled Trials
Pooled five RCTs comparing ADSC/SVF injection with placebo or hyaluronic acid, finding significant pain and function improvement at 6 and 12 months.
- 2023
- South Korea
- Level AMeta-analysis
Rapid-acting pain relief in knee osteoarthritis: autologous-cultured adipose-derived mesenchymal stem cells outperform stromal vascular fraction: a systematic review and meta-analysis
Analysed 31 studies with 1,406 patients: cultured ADMSCs reduced pain from month 3, whereas SVF reached significance only at 12 months.
- 2024
- South Korea
- n = 1406